Digital Pharma Innovation Week has ended
avatar for Martin Jernigan, RPh, PhD

Martin Jernigan, RPh, PhD

Akebia Therapeutics
Vice President, Marketing
Martin has over 25 years of pharmaceutical commercial and strategic leadership through roles of increasing responsibility for U.S. and global cross-functional and commercial teams. Areas have included product launches, life cycle management, licensing and business development, alliance management, marketing/sales. While at Novo Nordisk, his team managed an insulin portfolio (mature and launch brands) generating $4.5B in annual sales and grew the GLP1 brands to $2B in sales. Specifically, the GLP1 efforts included the pre-launch and launch of Victoza® exceeding forecast (2.4X target) and surpassing $2B mark (the first brand to achieve this). Earlier in his career, he worked in commercial, business development, strategy and marketing roles of increasing responsibility at Johnson & Johnson, Aventis, Hoechst Marion Roussel and Marion Merrell Dow. Martin received his Pharmacy degree from Auburn University and a Master of Science and Ph.D. in Health Care Administration with a concentration in Pharmaceutical Marketing from the University of Mississippi. He currently teaches a course in US Healthcare and Pharmaceutical Marketing at Rutgers MBA global business management program. Martin has a wonderful wife, Mary, three children (Jay, Clare, Grace) and two Portuguese water dogs (Goldie and Chief).